Literature DB >> 27558179

Cerebrospinal Fluid (1,3)-Beta-d-Glucan Testing Is Useful in Diagnosis of Coccidioidal Meningitis.

David A Stevens1, Yonglong Zhang2, Malcolm A Finkelman2, Demosthenes Pappagianis3, Karl V Clemons4, Marife Martinez4.   

Abstract

Diagnosing coccidioidal meningitis (CM) can be problematic owing to its infrequency and/or a delay in the positivity of a cerebrospinal fluid (CSF) culture or CSF antibody, particularly if the primary coccidioidal infection is unrecognized. We tested 37 CSF specimens, 26 from patients with confirmed CM and 11 from patients with suspected microbial meningitis without fungal diagnosis, for (1,3)-beta-glucan (BG). BG in CM CSF specimens ranged from 18 to 3,300 pg/ml and in controls ranged from <3.9 to 103 pg/ml. Diagnostic performance was determined using a 31-pg/ml cutoff (the bottom of the serum range according to the directions for the commercial kit, although further serial dilutions of the standard indicated linearity to 3.9). Sensitivity was 96%, specificity was 82%, positive and negative predictive values were 93% and 90%, and the area under the receiver operating characteristic curve was 0.937. Fifteen of 15 samples of >103 pg/ml were CM. The one false-negative specimen was from a patient with a pseudosyrinx, without inflammatory evidence of meningitis activity. Serial samples from some patients were positive at ≤8 years, indicating no loss of positivity with chronicity. Samples stored frozen since 2000 included those with 2 of the 3 highest values, indicating that fresh samples not required. A previous study indicated serum sensitivities of 53% in acute, 50% in resolved, and 83% in disseminated and meningeal coccidioidomycosis. Three studies of other fungal meningitides ranged from 86 to 1,524 pg/ml CSF, with 37 controls of <4 to 115 pg/ml CSF. CSF BG analysis had good diagnostic performance in CM. CSF BG testing can be useful in CM, and a commercial kit is available. It will be of interest to correlate this with course, treatment, outcome, inflammation, and antigen. The only mycoses with common central nervous system (CNS) involvement are cryptococcal and coccidioidal, so CSF BG screening can be useful in meningitis diagnosis.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27558179      PMCID: PMC5078547          DOI: 10.1128/JCM.01224-16

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  26 in total

1.  Post-diagnostic kinetics of the (1 → 3)-β-D-glucan assay in invasive aspergillosis, invasive candidiasis and Pneumocystis jirovecii pneumonia.

Authors:  S Koo; L R Baden; F M Marty
Journal:  Clin Microbiol Infect       Date:  2012-03-08       Impact factor: 8.067

2.  Serum (1->3)-β-D-glucan measurement in coccidioidomycosis.

Authors:  George R Thompson; Derek J Bays; Suzanne M Johnson; Stuart H Cohen; Demosthenes Pappagianis; Malcolm A Finkelman
Journal:  J Clin Microbiol       Date:  2012-06-12       Impact factor: 5.948

3.  A comparison of confidence/credible interval methods for the area under the ROC curve for continuous diagnostic tests with small sample size.

Authors:  Dai Feng; Giuliana Cortese; Richard Baumgartner
Journal:  Stat Methods Med Res       Date:  2015-08-30       Impact factor: 3.021

4.  Specificity of mannan antigen and anti-mannan antibody screening in patients with haematological malignancies at risk for fungal infection.

Authors:  Wiebke Duettmann; Christoph Koidl; Robert Krause; Gertrude Lackner; Albert Woelfler; Martin Hoenigl
Journal:  Mycoses       Date:  2016-02-25       Impact factor: 4.377

5.  Soluble (1-->3)-beta-D-glucan purified from Candida albicans: biologic effects and distribution in blood and organs in rabbits.

Authors:  M Yoshida; R I Roth; C Grunfeld; K R Feingold; J Levin
Journal:  J Lab Clin Med       Date:  1996-07

6.  Utility of (1-3)-β-D-glucan testing for diagnostics and monitoring response to treatment during the multistate outbreak of fungal meningitis and other infections.

Authors:  Anastasia P Litvintseva; Mark D Lindsley; Lalitha Gade; Rachel Smith; Tom Chiller; Jennifer L Lyons; Kiran T Thakur; Sean X Zhang; Dale E Grgurich; Thomas M Kerkering; Mary E Brandt; Benjamin J Park
Journal:  Clin Infect Dis       Date:  2013-12-12       Impact factor: 9.079

Review 7.  Serology of coccidioidomycosis.

Authors:  D Pappagianis; B L Zimmer
Journal:  Clin Microbiol Rev       Date:  1990-07       Impact factor: 26.132

8.  Utility of measuring (1,3)-β-d-glucan in cerebrospinal fluid for diagnosis of fungal central nervous system infection.

Authors:  Jennifer L Lyons; Kiran T Thakur; Rick Lee; Tonya Watkins; Carlos A Pardo; Kathryn A Carson; Barbara Markley; Malcolm A Finkelman; Kieren A Marr; Karen L Roos; Sean X Zhang
Journal:  J Clin Microbiol       Date:  2014-11-05       Impact factor: 5.948

9.  Efficacy of amphotericin B lipid complex in a rabbit model of coccidioidal meningitis.

Authors:  Javier Capilla; Karl V Clemons; Raymond A Sobel; David A Stevens
Journal:  J Antimicrob Chemother       Date:  2007-07-23       Impact factor: 5.790

10.  Pharmacokinetics, biological effects, and distribution of (1-->3)-beta-D-glucan in blood and organs in rabbits.

Authors:  M Yoshida; R I Roth; C Grunfeld; K R Feingold; J Levin
Journal:  Mediators Inflamm       Date:  1997       Impact factor: 4.711

View more
  10 in total

1.  The diagnostic performance of the beta-glucan assay in the detection of intra-amniotic infection with Candida species.

Authors:  Percy Pacora; Roberto Romero; Offer Erez; Eli Maymon; Bogdan Panaitescu; Juan Pedro Kusanovic; Adi L Tarca; Chaur-Dong Hsu; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2017-12-27

2.  Detection of (1,3)-β-d-Glucan in Cerebrospinal Fluid in Histoplasma Meningitis.

Authors:  Thein Myint; Felicia C Chow; Karen C Bloch; Luke Raymond-Guillen; Thomas E Davis; Patty W Wright; Laila Woc-Colburn; Raed N Khairy; Alan C Street; Tomotaka Yamamoto; Amanda Albers; L Joseph Wheat; Chadi A Hage
Journal:  J Clin Microbiol       Date:  2018-09-25       Impact factor: 5.948

3.  Efficacy of Cerebrospinal Fluid Beta-d-Glucan Diagnostic Testing for Fungal Meningitis: a Systematic Review.

Authors:  Christian Davis; L Joseph Wheat; Thein Myint; David R Boulware; Nathan C Bahr
Journal:  J Clin Microbiol       Date:  2020-03-25       Impact factor: 5.948

Review 4.  Recent trends in molecular diagnostics of yeast infections: from PCR to NGS.

Authors:  Toni Gabaldón
Journal:  FEMS Microbiol Rev       Date:  2019-09-01       Impact factor: 16.408

Review 5.  Translational Development and Application of (1→3)-β-d-Glucan for Diagnosis and Therapeutic Monitoring of Invasive Mycoses.

Authors:  Matthew W McCarthy; Ruta Petraitiene; Thomas J Walsh
Journal:  Int J Mol Sci       Date:  2017-05-24       Impact factor: 5.923

Review 6.  Methods for rapid diagnosis of meningitis etiology in adults.

Authors:  Victoria Poplin; David R Boulware; Nathan C Bahr
Journal:  Biomark Med       Date:  2020-04-09       Impact factor: 2.851

Review 7.  Central Nervous System Infections Due to Coccidioidomycosis.

Authors:  Niki R Jackson; Janis E Blair; Neil M Ampel
Journal:  J Fungi (Basel)       Date:  2019-06-28

8.  A case report of Coccidioides posadasii meningoencephalitis in an immunocompetent host.

Authors:  Raynell Lang; William Stokes; Jane Lemaire; Andrew Johnson; John Conly
Journal:  BMC Infect Dis       Date:  2019-08-16       Impact factor: 3.090

9.  Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium.

Authors:  J Peter Donnelly; Sharon C Chen; Carol A Kauffman; William J Steinbach; John W Baddley; Paul E Verweij; Cornelius J Clancy; John R Wingard; Shawn R Lockhart; Andreas H Groll; Tania C Sorrell; Matteo Bassetti; Hamdi Akan; Barbara D Alexander; David Andes; Elie Azoulay; Ralf Bialek; Robert W Bradsher; Stephane Bretagne; Thierry Calandra; Angela M Caliendo; Elio Castagnola; Mario Cruciani; Manuel Cuenca-Estrella; Catherine F Decker; Sujal R Desai; Brian Fisher; Thomas Harrison; Claus Peter Heussel; Henrik E Jensen; Christopher C Kibbler; Dimitrios P Kontoyiannis; Bart-Jan Kullberg; Katrien Lagrou; Frédéric Lamoth; Thomas Lehrnbecher; Jurgen Loeffler; Olivier Lortholary; Johan Maertens; Oscar Marchetti; Kieren A Marr; Henry Masur; Jacques F Meis; C Orla Morrisey; Marcio Nucci; Luis Ostrosky-Zeichner; Livio Pagano; Thomas F Patterson; John R Perfect; Zdenek Racil; Emmanuel Roilides; Marcus Ruhnke; Cornelia Schaefer Prokop; Shmuel Shoham; Monica A Slavin; David A Stevens; George R Thompson; Jose A Vazquez; Claudio Viscoli; Thomas J Walsh; Adilia Warris; L Joseph Wheat; P Lewis White; Theoklis E Zaoutis; Peter G Pappas
Journal:  Clin Infect Dis       Date:  2020-09-12       Impact factor: 9.079

10.  Isavuconazole Treatment of Spinal Cord Invasive Aspergillosis Guided by Cerebrospinal Fluid (1,3)-β-d-Glucan Levels in a Patient with Low Interferon-Gamma and Ulcerative Colitis.

Authors:  Siobhan O'Regan; Brendan O'Kelly; Paul Reidy; Aoibhlinn O'Toole; John Caird; Cora McNally; Samuel McConkey; Eoghan De Barra
Journal:  J Fungi (Basel)       Date:  2022-05-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.